Cargando…

Minimal clinically important difference of improvement on the Arm Function in Multiple Sclerosis Questionnaire (AMSQ)

BACKGROUND: The Arm Function in Multiple Sclerosis Questionnaire (AMSQ) has been developed to assess upper extremity function of patients with multiple sclerosis (MS). A minimal clinically important difference (MCID) value has not been determined yet. OBJECTIVE: The objective of this study is to det...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Munster, Caspar EP, Kaya, Levent, Obura, Morgan, Kalkers, Nynke F, Uitdehaag, Bernard MJ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Short Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140338/ https://www.ncbi.nlm.nih.gov/pubmed/30657002 http://dx.doi.org/10.1177/1352458518823489

Ejemplares similares

Development of the Arm Function in Multiple Sclerosis Questionnaire-Short Form (AMSQ-SF): A static 10-item version
por: Luijten, Michiel AJ, et al.
Publicado: (2018)

Reference videos reduce variability of motor dysfunction assessments in multiple sclerosis
por: D’Souza, Marcus, et al.
Publicado: (2018)

The clinical value of the patient-reported multiple sclerosis neuropsychological screening questionnaire
por: Nauta, Ilse M, et al.
Publicado: (2018)

Outcome Measures in Clinical Trials for Multiple Sclerosis
por: van Munster, Caspar E. P., et al.
Publicado: (2017)

Tasks of activities of daily living (ADL) are more valuable than the classical neurological examination to assess upper extremity function and mobility in multiple sclerosis
por: van Munster, Caspar EP, et al.
Publicado: (2018)

Minimal important change and responsiveness of the Migraine Disability Assessment Score (MIDAS) questionnaire
por: Carvalho, Gabriela F., et al.
Publicado: (2021)

Anxiety is more important than depression in MS – Commentary
por: de Jong, Brigit A, et al.
Publicado: (2018)

Patient-reported questionnaires in MS rehabilitation: responsiveness and minimal important difference of the multiple sclerosis questionnaire for physiotherapists (MSQPT)
por: van der Maas, Nico Arie
Publicado: (2017)

Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic
por: van Lierop, Zoë YGJ, et al.
Publicado: (2021)

Responsiveness and minimal important change of the Norwegian version of the Disabilities of the Arm, Shoulder and Hand questionnaire (DASH) in patients with subacromial pain syndrome
por: Rysstad, Tarjei, et al.
Publicado: (2017)

Cognitive functioning in everyday life: The development of a questionnaire on instrumental activities of daily living in multiple sclerosis
por: van Dam, Maureen, et al.
Publicado: (2021)

Infusion-related events during natalizumab: No need for post-infusion monitoring
por: Loonstra, Floor C, et al.
Publicado: (2019)

Update on the psychometric properties and minimal important difference (MID) thresholds of the FACT-M questionnaire for use in treatment-naïve and previously treated patients with metastatic Merkel cell carcinoma
por: Bharmal, Murtuza, et al.
Publicado: (2020)

Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change
por: de Vet, Henrica C, et al.
Publicado: (2006)

Determining the Minimal Important Difference for the Wound-QoL Questionnaire
por: Topp, Janine, et al.
Publicado: (2021)

Disability Outcome Measures in Phase III Clinical Trials in Multiple Sclerosis
por: Uitdehaag, Bernard M. J.
Publicado: (2018)

Multiple sclerosis and pregnancy: what does the patient think? a questionnaire study
por: Albrecht, Peter, et al.
Publicado: (2010)

The minimal important change for the seven-item disability of the arm, shoulder, and hand (DASH 7) questionnaire – Assessing shoulder function in patients with subacromial pain
por: Nordqvist, Jenny M., et al.
Publicado: (2021)

Responsiveness and minimal important change for the quick-DASH in patients with shoulder disorders
por: Budtz, Cecilie Rud, et al.
Publicado: (2018)

Disease activity following pregnancy-related discontinuation of natalizumab in MS
por: Kleerekooper, Iris, et al.
Publicado: (2017)

Minimally important difference of the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q)
por: Rejas, Javier, et al.
Publicado: (2011)

The PAC‐SYM questionnaire for chronic constipation: defining the minimal important difference
por: Yiannakou, Y., et al.
Publicado: (2017)

The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important difference
por: Masoli, Matthew, et al.
Publicado: (2021)

Minimal clinically important difference of the Trapeziometacarpal Arthrosis Symptoms and Disability questionnaire
por: Florczynski, Matthew, et al.
Publicado: (2022)

Retinal atrophy in relation to visual functioning and vision-related quality of life in patients with multiple sclerosis
por: Balk, Lisanne J, et al.
Publicado: (2017)

Leveraging real-world data to investigate multiple sclerosis disease behavior, prognosis, and treatment
por: Cohen, Jeffrey A, et al.
Publicado: (2019)

Prevalence of genital chlamydia infection in urban women of reproductive age, Nairobi, Kenya
por: Kohli, Ruchika, et al.
Publicado: (2013)

Responsiveness and minimal clinically important difference of the Minnesota living with heart failure questionnaire
por: Gonzalez-Saenz de Tejada, M., et al.
Publicado: (2019)

Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers
por: Coric, Danko, et al.
Publicado: (2017)

Determination of thresholds for minimally important difference and clinically important response on the functional outcomes of sleep questionnaire short version in adults with narcolepsy or obstructive sleep apnea
por: Weaver, Terri E., et al.
Publicado: (2021)

The Risk of Fracture in Patients With Multiple Sclerosis: The UK General Practice Research Database
por: Bazelier, Marloes T, et al.
Publicado: (2011)

Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire
por: Kocks, JWH, et al.
Publicado: (2006)

Determining minimal important change for the thyroid-related quality of life questionnaire ThyPRO
por: Nordqvist, Selma Flora, et al.
Publicado: (2021)

Responsiveness and Minimal Clinically Important Difference of the Infants and Toddlers Dermatology Quality of Life Questionnaire
por: Chernyshov, Pavel V., et al.
Publicado: (2023)

Autonomic Dysregulation, Cognitive Impairment, and Symptoms of Psychosis as an Unusual Presentation in an Anti-Aquaporin 4-Positive Patient
por: Ruiter, Annabel M., et al.
Publicado: (2017)

Asymptomatic spinal cord lesions do not predict the time to disability in patients with early multiple sclerosis
por: Dekker, Iris, et al.
Publicado: (2017)

Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis
por: Daruwalla, Cyrus, et al.
Publicado: (2023)

Natalizumab concentrations during pregnancy in three patients with multiple sclerosis
por: Toorop, Alyssa A, et al.
Publicado: (2021)

Prognostic factors for long-term outcomes in relapsing–remitting multiple sclerosis
por: Traboulsee, Anthony L, et al.
Publicado: (2016)

Minimal clinically important difference for the rhinoconjunctivitis quality of life questionnaire in allergic rhinitis in Thai population
por: Tantilipikorn, Pongsakorn, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o25es2i1tkl2husaaf7h5tltbe